Thiti Atjimakul

6PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersPreventative health careCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2026
Survival outcomes of expansile versus infiltrative subtype in primary mucinous ovarian carcinomas: A retrospective study in Thailand.

|Jan 06, 2026
Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high-grade cervical intraepithelial neoplasia.

Pattharapa Watcharasin, Nathapol Sirimusika, Thiti Atjimakul

|Mar 28, 2024
Significance of Pretreatment Hemoglobin-Albumin-Lymphocyte-Platelet Index for the Prediction of Suboptimal Surgery in Epithelial Ovarian Cancer.

Thiti Atjimakul, Nungrutai Saeaib, Thara Tunthanathip

|Jul 28, 2022
Salvage Treatment and Outcomes of Locally Advanced Cervical Cancer after Failed Concurrent Chemoradiation with or without Adjuvant Chemotherapy: Post Hoc Data Analysis from the ACTLACC Trial.

Tussawan Asakij, Jakkapan Khunnarong, Siriwan Tangjitgamol

|Sep 28, 2021
Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial.

Chokaew Tovanabutra, Tussawan Asakij, Kanisa Rongsriyam

|May 11, 2019
A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial.

Siriwan Tangjitgamol, Ekkasit Tharavichitkul, Chokaew Tovanabutra

Pageof 1

Frequent Collaborators

3 joint publications

Chokaew Tovanabutra

3 joint publications

Kanisa Rongsriyam

3 joint publications

Tussawan Asakij

3 joint publications

Kannika Paengchit